Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

A groundbreaking treatment for type 2 diabetes has emerged, offering hope to millions of patients worldwide. This innovative ...

Revolutionary glucose-responsive insulin NNC2215 offers hope for diabetics, managing blood sugar levels without hypoglycemia ...

At a meeting of the Food and Drug Administration’s (FDA) Endocrinologic and Metabolic Drugs Advisory Committee, the majority of panel members voted against the approval of sotagliflozin (Zynquista™) ...

Marlaina Goedel, diagnosed at age 5, said she is no longer on insulin. For Dr. Daniel Gilada, a husband, physician and soon-to-be father of four, living with Type 1 diabetes had become “overwhelming.” ...

Hybrid closed-loop insulin therapy prevents low night-time blood glucose levels among breastfeeding mothers with type 1 ...

Early morning hyperglycemia is sometimes called the “dawn phenomenon.” Left untreated, it can drive poorer outcomes. How can ...

Type 1 diabetes in China has successfully undergone a stem-cell therapy that enabled her to produce her own insulin, reducing ...

As per a report by Livescience, the team extracted fat cells from a woman with type 1 diabetes and chemically reverted these ...

“These results support the continued investigation of intranasal insulin and empagliflozin combination therapy for AD,” they ...

Insulcloud today announced its strategic expansion into the U.S. following FDA clearance for its Insulclock CAP smart device.

Early research shows the CD40L antibody tegoprubart is able to reduce insulin dependence in patients with type 1 diabetes after islet transplants.